ANA

Antinuclear Antibodies

Q: I have a positive ANA—does this mean I have lupus?

Not necessarily. A positive ANA is found in many conditions and in up to 15–20% of healthy people, especially women and older adults. The ANA test is very sensitive for lupus (>95% of lupus patients are ANA-positive) but not very specific. A diagnosis of lupus requires a combination of clinical features (rash, joint pain, kidney disease, blood count abnormalities) plus supportive lab findings. Think of the ANA as an initial screening test that, when positive, prompts more specific testing.

Immune & Inflammation

What is Antinuclear Antibodies?

Antinuclear antibodies (ANA) are autoantibodies directed against various components of the cell nucleus, including DNA, histones, nucleolar proteins, centromeres, and other nuclear antigens. The ANA test is the most widely used screening test for systemic autoimmune diseases, particularly systemic lupus erythematosus (SLE). The standard testing method is indirect immunofluorescence (IIF) on HEp-2 cells, which allows visualization of the staining pattern—a critical piece of diagnostic information. Results are reported as a titer (e.g., 1:80, 1:160, 1:320) reflecting the highest dilution at which fluorescence is still detected, along with the pattern of nuclear staining.

The ANA staining pattern provides clues to the specific autoantibodies present and the likely diagnosis: homogeneous pattern suggests anti-dsDNA or anti-histone antibodies (associated with SLE and drug-induced lupus); speckled pattern suggests anti-Smith, anti-RNP, anti-SSA/Ro, or anti-SSB/La antibodies (associated with SLE, mixed connective tissue disease, or Sjogren's syndrome); centromere pattern is highly specific for limited cutaneous systemic sclerosis (CREST syndrome); and nucleolar pattern suggests anti-RNA polymerase or anti-Scl-70 antibodies (associated with systemic sclerosis). A positive ANA alone does not diagnose any disease—it must be interpreted in clinical context.

Why It Matters

The ANA test is the gateway screening test for systemic autoimmune diseases. A negative ANA at 1:80 or higher effectively rules out SLE (sensitivity >95%). However, a positive ANA is found in many conditions beyond autoimmune disease—up to 15–20% of healthy individuals have a low-titer positive ANA, and prevalence increases with age, particularly in women. The clinical value of an ANA test depends entirely on the pre-test probability: ordering it in a patient with joint pain, rash, serositis, and cytopenias is highly informative, while ordering it as a nonspecific "screening" test in patients with vague fatigue often leads to unnecessary anxiety and further testing.

Normal Reference Ranges

Group	Range	Unit
Negative	<1:40	titer
Low positive (often clinically insignificant)	1:40–1:80	titer
Moderate positive	1:160–1:320	titer
High positive (more likely clinically significant)	≥1:640	titer

Reference ranges may vary by laboratory. Always compare results to the ranges provided by your testing facility.

What High ANA Levels Mean

Common Causes

Systemic lupus erythematosus (SLE)—positive in >95% of cases
Drug-induced lupus (hydralazine, procainamide, isoniazid)
Sjogren's syndrome
Systemic sclerosis (scleroderma)
Mixed connective tissue disease
Polymyositis/dermatomyositis
Autoimmune hepatitis
Rheumatoid arthritis (in some patients)
Healthy individuals (up to 15–20%, usually low titer)
Older age (higher prevalence of low-titer positive ANA)
Infections (EBV, hepatitis C) and certain medications

Possible Symptoms

A positive ANA itself does not cause symptoms
Symptoms depend on the underlying condition—may include joint pain, skin rashes, fatigue, mouth ulcers, hair loss, Raynaud's phenomenon, dry eyes/mouth, or muscle weakness

What to do: A positive ANA should prompt evaluation of the clinical picture. If autoimmune disease is suspected, order specific antibodies based on the ANA pattern: anti-dsDNA and anti-Smith for SLE, anti-SSA/SSB for Sjogren's, anti-centromere and anti-Scl-70 for systemic sclerosis, anti-Jo-1 for myositis. Check complement levels (C3, C4), CBC, urinalysis, and inflammatory markers. A low-titer ANA (≤1:80) in the absence of suggestive symptoms generally does not warrant further testing. Refer to rheumatology when clinical features align with a systemic autoimmune disease.

What Low ANA Levels Mean

Common Causes

A negative ANA is the normal result
ANA-negative lupus occurs rarely (<5% of SLE cases)—these patients may have anti-Ro/SSA antibodies detectable by other methods

Possible Symptoms

No symptoms from a negative ANA

What to do: A negative ANA is reassuring and effectively rules out SLE in most cases. If clinical suspicion for SLE or Sjogren's remains high despite a negative ANA, consider testing for anti-Ro/SSA antibodies specifically, as these can be present in ANA-negative lupus. No follow-up testing is needed for a negative ANA in the absence of clinical concern.

When Is ANA Testing Recommended?

When systemic lupus erythematosus is clinically suspected (malar rash, photosensitivity, joint pain, serositis, cytopenias)
When Sjogren's syndrome is suspected (dry eyes, dry mouth, parotid swelling)
When systemic sclerosis is suspected (Raynaud's, skin thickening, digital ulcers)
As part of the workup for unexplained inflammatory arthritis
When autoimmune hepatitis is suspected

Frequently Asked Questions

Not necessarily. A positive ANA is found in many conditions and in up to 15–20% of healthy people, especially women and older adults. The ANA test is very sensitive for lupus (>95% of lupus patients are ANA-positive) but not very specific. A diagnosis of lupus requires a combination of clinical features (rash, joint pain, kidney disease, blood count abnormalities) plus supportive lab findings. Think of the ANA as an initial screening test that, when positive, prompts more specific testing.

The immunofluorescence pattern on HEp-2 cells reflects which nuclear components the antibodies target. A homogeneous pattern is commonly associated with lupus (anti-dsDNA, anti-histone). A speckled pattern can be seen in many autoimmune conditions (lupus, Sjogren's, MCTD). A centromere pattern is highly associated with limited systemic sclerosis (CREST). A nucleolar pattern suggests systemic sclerosis. The pattern helps guide which specific antibody tests to order next.

Generally, repeating an ANA test is not recommended if a reliable result has been obtained. ANA titers can fluctuate but do not reliably track disease activity. Once a positive ANA has been established and specific antibodies identified, follow-up monitoring should focus on disease-specific markers (e.g., anti-dsDNA titers and complement levels for lupus) rather than re-checking the ANA.

Related Biomarkers

Anti-dsDNAAnti-dsDNA Antibodies C3Complement C3 C4Complement C4 ESRErythrocyte Sedimentation Rate CRPC-Reactive Protein

Want your ANA levels analyzed?

Upload your lab results for an instant AI-powered breakdown of all your biomarkers.

Upload Lab Results →

Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Reference ranges may vary between laboratories. Always consult your healthcare provider for interpretation of your specific test results.